Gulf International Bank UK Ltd Lowers Stock Position in The Cooper Companies, Inc. (NASDAQ:COO)

Gulf International Bank UK Ltd lowered its position in The Cooper Companies, Inc. (NASDAQ:COO) by 0.9% in the 4th quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The fund owned 15,481 shares of the medical device company’s stock after selling 145 shares during the period. Gulf International Bank UK Ltd’s holdings in Cooper Companies were worth $1,423,000 at the end of the most recent reporting period.

Several other institutional investors and hedge funds also recently made changes to their positions in the company. Fulton Bank N.A. raised its holdings in shares of Cooper Companies by 3.0% in the fourth quarter. Fulton Bank N.A. now owns 3,718 shares of the medical device company’s stock valued at $342,000 after purchasing an additional 109 shares during the last quarter. Mather Group LLC. grew its position in Cooper Companies by 7.4% during the fourth quarter. Mather Group LLC. now owns 1,926 shares of the medical device company’s stock valued at $177,000 after buying an additional 133 shares during the period. MassMutual Private Wealth & Trust FSB grew its position in Cooper Companies by 15.6% during the fourth quarter. MassMutual Private Wealth & Trust FSB now owns 1,008 shares of the medical device company’s stock valued at $93,000 after buying an additional 136 shares during the period. Greenleaf Trust grew its position in Cooper Companies by 5.0% during the fourth quarter. Greenleaf Trust now owns 2,915 shares of the medical device company’s stock valued at $268,000 after buying an additional 139 shares during the period. Finally, UMB Bank n.a. grew its position in Cooper Companies by 22.5% during the fourth quarter. UMB Bank n.a. now owns 773 shares of the medical device company’s stock valued at $71,000 after buying an additional 142 shares during the period. Hedge funds and other institutional investors own 24.39% of the company’s stock.

Analyst Upgrades and Downgrades

COO has been the subject of several research reports. Wells Fargo & Company increased their price target on shares of Cooper Companies from $115.00 to $118.00 and gave the company an “overweight” rating in a research report on Friday, December 6th. Morgan Stanley reduced their price target on shares of Cooper Companies from $104.00 to $102.00 and set an “equal weight” rating for the company in a research report on Friday, December 6th. StockNews.com lowered shares of Cooper Companies from a “buy” rating to a “hold” rating in a research report on Wednesday, December 11th. Citigroup cut their target price on shares of Cooper Companies from $116.00 to $115.00 and set a “buy” rating for the company in a research report on Friday, December 6th. Finally, Needham & Company LLC reiterated a “hold” rating on shares of Cooper Companies in a research report on Friday, December 6th. Three research analysts have rated the stock with a hold rating and eight have given a buy rating to the company’s stock. Based on data from MarketBeat.com, the company has an average rating of “Moderate Buy” and an average price target of $117.22.

Cooper Companies Price Performance

Shares of NASDAQ:COO opened at $90.38 on Friday. The Cooper Companies, Inc. has a twelve month low of $84.76 and a twelve month high of $112.38. The firm has a market capitalization of $18.04 billion, a PE ratio of 46.35, a P/E/G ratio of 2.25 and a beta of 1.00. The company has a quick ratio of 1.12, a current ratio of 1.91 and a debt-to-equity ratio of 0.32. The company has a 50-day moving average price of $92.64 and a two-hundred day moving average price of $99.53.

Cooper Companies (NASDAQ:COO) last announced its quarterly earnings results on Thursday, December 5th. The medical device company reported $1.04 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $1.00 by $0.04. Cooper Companies had a net margin of 10.07% and a return on equity of 9.38%. The firm had revenue of $1.02 billion for the quarter, compared to the consensus estimate of $1.03 billion. During the same period in the prior year, the firm posted $0.87 earnings per share. The company’s revenue for the quarter was up 9.8% on a year-over-year basis. Equities analysts forecast that The Cooper Companies, Inc. will post 3.98 EPS for the current year.

About Cooper Companies

The Cooper Companies, Inc, together with its subsidiaries, develops, manufactures, and markets contact lens wearers. The company operates in two segments, CooperVision and CooperSurgical. The CooperVision segment provides spherical lense, including lenses that correct near and farsightedness; and toric and multifocal lenses comprising lenses correcting vision challenges, such as astigmatism, presbyopia, and myopia in the Americas, Europe, Middle East, Africa, and Asia Pacific.